Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
SeaStar Medical Holding ( (ICU) ) has shared an announcement.
On June 20, 2025, SeaStar Medical Holding Corporation announced a public offering of shares and warrants, expected to raise approximately $3.39 million in net proceeds, which will be used for general corporate purposes. The offering closed on June 23, 2025, and is part of the company’s efforts to comply with Nasdaq’s listing requirements. Additionally, SeaStar Medical implemented cost-cutting measures, including a 20% salary reduction for executives and directors, to reduce monthly operating expenses by approximately $50,000.
The most recent analyst rating on (ICU) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on SeaStar Medical Holding stock, see the ICU Stock Forecast page.
Spark’s Take on ICU Stock
According to Spark, TipRanks’ AI Analyst, ICU is a Underperform.
SeaStar Medical Holding faces significant financial challenges, with negative equity and reliance on external financing posing risks to its financial health. Technical indicators show bearish momentum, and valuation metrics highlight ongoing losses, contributing to a low overall stock score.
To see Spark’s full report on ICU stock, click here.
More about SeaStar Medical Holding
SeaStar Medical is a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The company’s first commercial product, QUELIMMUNE, was approved by the FDA in 2024 for treating life-threatening acute kidney injury due to sepsis in critically ill pediatric patients. SeaStar is also conducting a pivotal trial of its Selective Cytopheretic Device therapy for adult patients with acute kidney injury.
Average Trading Volume: 527,156
Technical Sentiment Signal: Sell
Current Market Cap: $3.95M
For detailed information about ICU stock, go to TipRanks’ Stock Analysis page.